FILTRIX Logo FILTRIX Find Your Edge β†’
Sector Report β€” Open SIC 2836 Β· 130 tickers

Biological Products, (No Diagnostic Substances)

SIC 2836 130 tickers analyzed 3,599 total alerts

Tickers
130
In this sector
Total alerts
3,599
Trade-Ideas signal history
Avg win rate
43.9%
Sector baseline
Avg gain
-0.54%
Per-alert expectancy

πŸ“ˆ Sector Performance by Timeframe

5-Minute

Avg Gain: -0.40%
Win Rate: 39.9%

15-Minute

Avg Gain: -0.58%
Win Rate: 41.1%

30-Minute

Avg Gain: -0.62%
Win Rate: 41.4%

60-Minute

Avg Gain: -0.78%
Win Rate: 41.9%

EOD

Avg Gain: -0.31%
Win Rate: 55.3%

MFE/MAE

Avg MFE: +6.62%
Avg MAE: -2.75%

πŸ“‹ Biological Products, (No Diagnostic Substances) Stocks (100)

All tickers in SIC 2836 with Trade-Ideas alert data, sorted by alert count.

# Ticker Company Market Cap Alerts Avg Win Rate Avg 5min MFE Action
1 DNA Ginkgo Bioworks Holdings, Inc. $679.4M 436 43.2% -0.59% +4.00% View β†’
2 OCGN Ocugen, Inc. Common Stock $511.2M 332 38.4% -0.63% +3.63% View β†’
3 NVAX Novavax Inc $1.60B 312 44.0% -0.27% +5.20% View β†’
4 MRNA Moderna, Inc. Common Stock $31.65B 173 50.0% +0.07% +3.82% View β†’
5 RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock $2.02B 147 44.8% -0.46% +4.58% View β†’
6 GILD Gilead Sciences Inc $162.98B 138 57.2% +0.10% +1.26% View β†’
7 PALI Palisade Bio, Inc. Common Stock $364.9M 118 42.1% -0.18% +9.75% View β†’
8 OTLK Outlook Therapeutics, Inc. Common Stock $215.5M 84 53.8% -0.01% +10.10% View β†’
9 AMGN Amgen Inc $201.93B 82 53.4% +0.03% +1.16% View β†’
10 IBRX ImmunityBio, Inc. Common Stock $9.89B 79 44.6% -0.97% +9.39% View β†’
11 SGMO SANGAMO THERAPEUTICS INC - 75 44.8% +0.12% +9.76% View β†’
12 PLX Protalix BioTherapeutics, Inc. Common Stock $186.9M 64 44.7% -0.23% +4.59% View β†’
13 IOVA Iovance Biotherapeutics, Inc. Common Stock $1.92B 63 43.5% -0.33% +4.85% View β†’
14 SNTI Senti Biosciences Holdings, Inc. Common Stock $33.3M 57 42.1% -0.80% +17.26% View β†’
15 XFOR X4 Pharmaceuticals, Inc. Common Stock $389.5M 57 38.2% -1.96% +8.62% View β†’
16 CELZ Creative Medical Technology Holdings, Inc. Common Stock $4.5M 51 42.2% -0.16% +9.61% View β†’
17 CHRS Coherus Oncology, Inc. Common Stock $223.7M 47 42.1% -0.37% +6.39% View β†’
18 TVGN Tevogen Bio Holdings Inc. Common Stock $24.3M 44 35.0% -0.26% +12.36% View β†’
19 BIIB Biogen Inc. Common Stock $31.91B 43 43.7% -0.38% +1.24% View β†’
20 ATRA Atara Biotherapeutics, Inc $105.0M 41 59.6% +0.56% +11.12% View β†’
21 CGTX Cognition Therapeutics, Inc. Common Stock $104.7M 40 38.5% -0.94% +8.30% View β†’
22 DBVT DBV Technologies S.A. $936.3M 39 45.5% -0.03% +6.61% View β†’
23 AGEN Agenus Inc. $145.3M 39 51.3% -0.53% +5.35% View β†’
24 CRIS Curis Inc - 33 35.2% -0.96% +6.76% View β†’
25 TSHA Taysha Gene Therapies, Inc. Common Stock $1.88B 32 39.4% -0.56% +9.76% View β†’
26 TNYA Tenaya Therapeutics, Inc. Common Stock $170.8M 30 38.7% -0.48% +7.07% View β†’
27 SLXN Silexion Therapeutics Corp Ordinary Shares $2.8M 30 42.7% -1.23% +12.55% View β†’
28 INAB IN8bio, Inc. Common Stock $13.6M 29 42.0% -0.66% +10.13% View β†’
29 SCLX Scilex Holding Company Common Stock $54.9M 29 44.8% -0.75% +7.03% View β†’
30 SLDB Solid Biosciences Inc. Common Stock $1.07B 25 54.4% -0.46% +9.05% View β†’
31 BCRX BioCryst Pharmaceuticals Inc $2.50B 25 60.0% -0.21% +6.68% View β†’
32 HUMA Humacyte, Inc. Common Stock $191.4M 25 44.8% -0.39% +7.22% View β†’
33 CADL Candel Therapeutics, Inc. Common Stock $720.2M 24 49.9% +1.30% +15.67% View β†’
34 DTIL Precision BioSciences, Inc. Common Stock $211.1M 24 42.0% -0.70% +4.55% View β†’
35 CVM Cel-Sci Corporation $19.9M 23 44.3% +0.39% +14.95% View β†’
36 BCDA BioCardia, Inc. Common Stock $17.9M 23 37.3% -0.08% +8.59% View β†’
37 CRSP CRISPR Therapeutics AG $5.92B 23 47.8% -0.34% +4.61% View β†’
38 CCCC C4 Therapeutics, Inc. $475.4M 23 57.4% +0.93% +16.24% View β†’
39 CRDF Cardiff Oncology, Inc. Common Stock $86.8M 22 39.4% +1.06% +9.83% View β†’
40 BDTX Black Diamond Therapeutics, Inc. Common Stock $115.2M 20 24.0% -1.25% +6.13% View β†’
41 IVVD Invivyd, Inc. Common Stock $263.3M 20 40.0% -1.59% +21.23% View β†’
42 JSPR Jasper Therapeutics, Inc. Common Stock $12.0M 20 51.0% +0.37% +17.19% View β†’
43 AIM AIM ImmunoTech Inc. $7.8M 19 35.1% -0.19% +5.34% View β†’
44 IKT Inhibikase Therapeutics, Inc. Common Stock $262.7M 17 38.5% -0.97% +8.23% View β†’
45 CRBU Caribou Biosciences, Inc. Common Stock $180.5M 16 30.0% -1.02% +4.77% View β†’
46 CABA Cabaletta Bio, Inc. Common Stock $520.1M 16 33.8% -1.14% +12.54% View β†’
47 PHGE BiomX Inc. $3.8M 15 49.7% +0.08% +11.53% View β†’
48 CLDI Calidi Biotherapeutics, Inc. $2.9M 15 30.7% -2.21% +13.97% View β†’
49 NBIX Neurocrine Biosciences Inc $17.52B 14 65.7% +0.14% +1.75% View β†’
50 SANA Sana Biotechnology, Inc. Common Stock $1.12B 14 45.7% +1.47% +8.65% View β†’
51 ADMA ADMA Biologics, Inc. $2.07B 14 57.1% +0.27% +6.88% View β†’
52 QNCX Quince Therapeutics, Inc. Common Stock $16.9M 14 26.2% -2.24% +7.08% View β†’
53 ALGS Aligos Therapeutics, Inc. Common Stock $34.6M 14 45.4% -2.25% +8.20% View β†’
54 EDIT Editas Medicine, Inc. Common Stock $560.1M 13 43.1% -0.94% +6.19% View β†’
55 AVXL Anavex Life Sciences $255.8M 13 23.1% -1.47% +5.25% View β†’
56 BCAB BioAtla, Inc. Common Stock $7.0M 13 26.5% -1.38% +8.39% View β†’
57 IMVT Immunovant, Inc. Common Stock $7.96B 12 56.7% +0.71% +8.78% View β†’
58 SABS SAB Biotherapeutics, Inc. Common Stock $299.7M 12 42.7% -2.22% +14.60% View β†’
59 VIR Vir Biotechnology, Inc. Common Stock $1.69B 12 25.0% -1.46% +4.22% View β†’
60 SRZN Surrozen, Inc. Common $289.3M 11 54.0% -0.50% +14.11% View β†’
61 KOD Kodiak Sciences Inc Common Stock $2.41B 11 60.0% +0.02% +13.78% View β†’
62 TCRX TScan Therapeutics, Inc. Common Stock $69.3M 10 53.1% +0.22% +25.40% View β†’
63 FDMT 4D Molecular Therapeutics, Inc. Common Stock $679.6M 10 32.0% -2.37% +6.07% View β†’
64 LCTX Lineage Cell Therapeutics, Inc. $336.6M 10 20.4% -0.71% +3.29% View β†’
65 NMRA Neumora Therapeutics, Inc. Common Stock $309.4M 10 61.3% +0.65% +8.94% View β†’
66 ABOS Acumen Pharmaceuticals, Inc. Common Stock $197.9M 10 28.0% -0.70% +8.74% View β†’
67 HALO Halozyme Therapeutics, Inc. $9.42B 10 30.2% -1.07% +1.45% View β†’
68 RVMD Revolution Medicines, Inc. Common Stock $40.23B 9 51.1% -2.20% +4.88% View β†’
69 FATE Fate Therapeutics, Inc. $340.4M 9 55.6% +3.69% +14.54% View β†’
70 RLAY Relay Therapeutics, Inc. Common Stock $4.06B 8 42.5% +0.17% +8.40% View β†’
71 BEAM Beam Therapeutics Inc. Common Stock $3.58B 8 55.0% +0.14% +8.05% View β†’
72 ALLO Allogene Therapeutics, Inc. Common Stock $717.9M 8 27.5% +0.55% +6.56% View β†’
73 TECH Bio-Techne Corp. $11.04B 8 47.9% -0.00% +1.24% View β†’
74 AUTL Autolus Therapeutics plc American Depositary Share $420.5M 8 22.5% -0.53% +3.79% View β†’
75 PMCB PharmaCyte Biotech, Inc. Common Stock $7.7M 7 20.0% -0.30% +2.05% View β†’
76 PASG Passage Bio, Inc. Common Stock $15.0M 7 65.7% +0.12% +14.14% View β†’
77 PCVX Vaxcyte, Inc. Common Stock $8.43B 7 51.4% +0.64% +6.08% View β†’
78 EXEL Exelixis Inc $14.04B 7 65.7% -0.11% +1.54% View β†’
79 INBX Inhibrx Biosciences, Inc. Common Stock $1.43B 6 64.7% +0.47% +6.34% View β†’
80 ZURA Zura Bio Limited Class A Ordinary Shares $490.5M 6 43.3% -0.10% +16.82% View β†’
81 TIL Instil Bio, Inc. Common Stock $52.4M 6 60.0% +0.68% +5.13% View β†’
82 SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares $1.4M 6 27.3% +2.64% +10.82% View β†’
83 DNLI Denali Therapeutics Inc. Common Stock $4.10B 6 33.3% -1.06% +4.83% View β†’
84 TWST Twist Bioscience Corporation Common Stock $6.18B 6 36.7% -0.76% +4.84% View β†’
85 STRO Sutro Biopharma, Inc. $504.2M 6 36.7% -1.31% +6.30% View β†’
86 ENTX Entera Bio Ltd. Ordinary Shares $81.8M 6 28.0% -0.96% +9.40% View β†’
87 SRRK Scholar Rock Holding Corporation Common Stock $6.58B 5 32.0% +0.26% +9.98% View β†’
88 MGX Metagenomi Therapeutics, Inc. Common Stock $47.4M 5 40.0% +3.16% +23.51% View β†’
89 ACLX Arcellx, Inc. Common Stock $3.91B 5 28.0% -1.21% +4.45% View β†’
90 REPL Replimune Group, Inc. $972.1M 5 68.0% -1.10% +7.54% View β†’
91 VOR Vor Biopharma Inc. Common Stock $1.12B 5 52.0% +2.16% +23.07% View β†’
92 KLTO Klotho Neurosciences, Inc. Common Stock $23.7M 4 20.0% +0.45% +10.33% View β†’
93 CMPX Compass Therapeutics, Inc. Common Stock $408.8M 4 25.0% -2.00% +18.76% View β†’
94 ALEC Alector, Inc. Common Stock $228.7M 4 10.0% -3.15% +3.21% View β†’
95 INKT MiNK Therapeutics, Inc. Common Stock $58.1M 4 41.7% -3.04% +11.47% View β†’
96 RGNX REGENXBIO Inc. $686.5M 4 30.0% -2.90% +2.05% View β†’
97 CGEM Cullinan Therapeutics, Inc. Common Stock $1.08B 4 15.0% -1.77% +2.69% View β†’
98 TARA Protara Therapeutics, Inc. Common Stock $228.2M 4 40.0% -0.06% +10.04% View β†’
99 TARS Tarsus Pharmaceuticals, Inc. Common Stock $2.82B 4 25.0% -1.94% +1.96% View β†’
100 PROK ProKidney Corp. Class A Ordinary Shares $416.6M 4 35.0% -1.14% +8.42% View β†’

πŸš€ Scan for Alpha in Biological Products, (No Diagnostic Substances)

Don't trade the whole basket.
Use FILTRIX to isolate the top performing stocks among the 130 companies in this sector. Filter by MFE, Volume, and Win Rate instantly.

Find Best Setups β†’

πŸ“Š Biological Products, (No Diagnostic Substances) Sector Intelligence

⚑ High Volatility Sector

The Biological Products, (No Diagnostic Substances) sector (SIC 2836) aggregates data from 130 stocks. With an average Maximum Favorable Excursion (MFE) of +6.62%, this sector is highly aggressive, suited for experienced volatility traders looking for explosive moves.

πŸ“ˆ Statistical Expectancy

Across 3,599 analyzed alerts, the sector shows a 43.9% Win Rate with an average gain of -0.54%.

⚠️ This suggests a difficult trading environment where strict stock selection is critical. Focus on the top performers within this sector.

πŸ† Sector Leader

The strongest statistical performer in this group is currently NBIX , boasting a 65.7% win rate across 14 alerts.

This significantly outperforms the sector average (43.9%), making it a primary watchlist candidate for traders seeking edge in this space.